Conmed (CNMD) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.96% |
| Dec 31, 2025 | -8.33% |
| Sep 30, 2025 | -1.81% |
| Jun 30, 2025 | 0.61% |
| Mar 31, 2025 | -7.86% |
| Dec 31, 2024 | 1.10% |
| Sep 30, 2024 | -5.05% |
| Jun 30, 2024 | -5.07% |
| Mar 31, 2024 | -7.66% |
| Dec 31, 2023 | -6.77% |
| Sep 30, 2023 | -0.54% |
| Jun 30, 2023 | -3.54% |
| Mar 31, 2023 | -4.63% |
| Dec 31, 2022 | 2.37% |
| Sep 30, 2022 | 5.40% |
| Jun 30, 2022 | -5.78% |
| Mar 31, 2022 | 6.43% |
| Dec 31, 2021 | 5.34% |
| Sep 30, 2021 | -3.18% |
| Jun 30, 2021 | -14.77% |
| Mar 31, 2021 | -13.07% |
| Dec 31, 2020 | 17.71% |
| Sep 30, 2020 | 11.43% |
| Jun 30, 2020 | 10.88% |
| Mar 31, 2020 | 18.04% |
| Dec 31, 2019 | 17.17% |
| Sep 30, 2019 | 14.19% |
| Jun 30, 2019 | 17.89% |
| Mar 31, 2019 | 16.10% |
| Dec 31, 2018 | 20.30% |
| Sep 30, 2018 | 9.84% |
| Jun 30, 2018 | 9.30% |
| Mar 31, 2018 | 8.17% |
| Dec 31, 2017 | -6.58% |
| Sep 30, 2017 | -17.31% |
| Jun 30, 2017 | -19.83% |
| Mar 31, 2017 | -12.24% |
| Dec 31, 2016 | -1.04% |
| Sep 30, 2016 | 7.54% |
| Jun 30, 2016 | 0.87% |
| Mar 31, 2016 | -2.09% |
| Dec 31, 2015 | -42.32% |
| Sep 30, 2015 | -31.64% |
| Jun 30, 2015 | -48.94% |